American Shared Hospital Services

  • Market Cap: Micro Cap
  • Industry: Finance
  • ISIN: US0295951059
USD
2.15
0.23 (11.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About American Shared Hospital Services stock-summary
stock-summary
American Shared Hospital Services
Finance
American Shared Hospital Services provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to approximately 20 medical centers in approximately 20 states in the United States. The Company provides Gamma Knife services through its over 81% indirect interest in GK Financing, LLC (GKF). The Company's business is the outsourcing of stereotactic radiosurgery services and radiation therapy services. The Company provides the equipment, as well as planning, installation, reimbursement and marketing support services. The Company's radiation therapy business consists of one Image Guided Radiation Therapy Operations (IGRT) system. IGRT technology integrates imaging and detection components into a linear accelerator, allowing clinicians to plan treatment, verify positioning and deliver treatment with a single device, providing radiation therapy with less damage to healthy tissue. It is also engaged in proton beam radiation therapy business (PBRT).
Company Coordinates stock-summary
Company Details
2 Embarcadero Ctr Ste 410 , SAN FRANCISCO CA : 94111-3822
stock-summary
Tel: 1 415 7885300
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 4 Schemes (7.53%)

Foreign Institutions

Held by 3 Foreign Institutions (0.13%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Raymond Stachowiak
Chief Executive Officer, Director
Mr. Saim Mert Ozyurek
Director
Mr. Daniel Kelly
Independent Director
Dr. David Larson
Independent Director
Ms. Sandra Lawrence
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
7 Million
(Quarterly Results - Jun 2025)
Net Profit:
0 Million
stock-summary
Industry

Finance

stock-summary
Market cap

USD 14 Million (Micro Cap)

stock-summary
P/E

3.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

2.71%

stock-summary
Price to Book

0.55